Skip to content

Enhancing the quality of life of tumor patients through hypnosystemic resource activation - a hypnotherapeutic short-term program to strengthen their own resources ("HypRa")

Enhancing the quality of life of tumor patients through hypnosystemic resource activation - a hypnotherapeutic short-term program to strengthen their own resources ("HypRa") - HypRa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00019095
Enrollment
60
Registered
2020-01-27
Start date
2017-05-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coping with oncological disease F43

Interventions

Group 1: Patients of the first intervention group (Hypnosystemic Therapy = HT) learned in three individual sessions the application of individual internal mental images for resource activation via sel

Sponsors

Universitätsklinikum Ulm. Klinik für Psychosomatische Medizin und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: Oncological patients with chemo- or immunotherapy

Exclusion criteria

Exclusion criteria: Cognitive or language limitations, severe psychiatric or neurological disorders

Design outcomes

Primary

MeasureTime frame
Changes in stress management and resource activation capabilities, measured by a standardized questionnaire survey at three measurement points of time.

Secondary

MeasureTime frame
Extent and coping with anxiety - in particular with the fear of progression of the disease (progredience anxiety) - and depressiveness, measured by a standardized questionnaire survey at three measuring points as well as via the evaluation of diary entries regarding individual resource activation.

Countries

Germany

Contacts

Public ContactNorbert Gelse

Universitätsklinikum Ulm. Klinik für Psychosomatische Medizin und Psychotherapie

Helga.Ostermayer@uniklinik-ulm.de0731 / 5 00-6 18 81

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026